Menu
Back to Journals » Cancer Management and Research » Volume 3 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4485)
- Volume 15, 2023 (44)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 3, 2011
Erratum
Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K
Cancer Management and Research 2011, 3:319-320
Published Date: 5 December 2011
Patient–provider communication data: linking process and outcomes in oncology care
Kennedy Sheldon L, Hong F, Berry DL
Cancer Management and Research 2011, 3:311-317
Published Date: 18 November 2011
Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver
Abedini F, Ismail M, Hosseinkhani H, Tengku Ibrahim TA, Omar AR, Chong PP, Hair Bejo M, Domb AJ
Cancer Management and Research 2011, 3:301-309
Published Date: 9 September 2011
Use of capecitabine in management of early colon cancer
Hameed H, Cassidy J
Cancer Management and Research 2011, 3:295-299
Published Date: 19 August 2011
Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?
Dimitropoulos C, Hillas G, Nikolakopoulou S, Kostara K, Sagris K, Vlastos F, Alchanatis M
Cancer Management and Research 2011, 3:287-294
Published Date: 17 August 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma
Bukowski RM
Cancer Management and Research 2011, 3:273-285
Published Date: 10 August 2011
Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C
Nojiri S, Kusakabe A, Shinkai N, Matsuura K, Iio E, Miyaki T, Joh T
Cancer Management and Research 2011, 3:267-272
Published Date: 28 July 2011
Latest developments and emerging treatment options in the management of stomach cancer
Delaunoit T
Cancer Management and Research 2011, 3:257-266
Published Date: 13 July 2011
Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique
Madhuri TK, Tailor A, Butler-Manuel S
Cancer Management and Research 2011, 3:253-255
Published Date: 6 July 2011
Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer
Krikeli M, Ekonomopoulou MT, Tzitzikas I, Goutzioulis A, Mystakidou K, Pistevou-Gompaki K
Cancer Management and Research 2011, 3:247-251
Published Date: 6 July 2011
Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population
Engel-Nitz NM, Alemayehu B, Parry D, Nathan F
Cancer Management and Research 2011, 3:233-245
Published Date: 4 July 2011
Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience
Moslemi MK, Lotfi F, Tahvildar SA
Cancer Management and Research 2011, 3:227-231
Published Date: 27 June 2011
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
Markman M
Cancer Management and Research 2011, 3:219-225
Published Date: 13 June 2011
Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia
Molica S, Mirabelli R, Molica M, Levato L, Mauro F, Foà R
Cancer Management and Research 2011, 3:211-217
Published Date: 1 June 2011
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort
Crawford ED, Phillips JM
Cancer Management and Research 2011, 3:201-209
Published Date: 20 July 2011
Deciding what information is necessary: do patients with advanced cancer want to know all the details?
Russell BJ, Ward AM
Cancer Management and Research 2011, 3:191-199
Published Date: 24 May 2011
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
Tawara K, Oxford JT, Jorcyk C
Cancer Management and Research 2011, 3:177-189
Published Date: 18 May 2011
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Wacheck V, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr W, Valent P
Cancer Management and Research 2011, 3:157-175
Published Date: 10 May 2011
Intercellular cancer collisions generate an ejected crystal comet tail effect with fractal interface embryoid body reassembly transformation
Díaz JA, Murillo MF, Barrero A
Cancer Management and Research 2011, 3:143-155
Published Date: 11 May 2011
Interpreting clinical assays for histone deacetylase inhibitors
Martinet N, Bertrand P
Cancer Management and Research 2011, 3:117-141
Published Date: 9 May 2011
Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
Abreu DS
Cancer Management and Research 2011, 3:109-116
Published Date: 21 April 2011
Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis
Coventry BJ, Weightman MJ, Skinner JM, Bradley J
Cancer Management and Research 2011, 3:101-108
Published Date: 18 April 2011
Chemoprevention of prostate cancer with nutrients and supplements
Van Poppel H, Tombal B
Cancer Management and Research 2011, 3:91-100
Published Date: 6 April 2011
Capecitabine in the management of colorectal cancer
Hirsch BR, Zafar SY
Cancer Management and Research 2011, 3:79-89
Published Date: 24 March 2011
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
David L DeRemer, Katerina Katsanevas, Celalettin Ustun
Cancer Management and Research 2011, 3:65-78
Published Date: 10 March 2011
Critical appraisal of trastuzumab in treatment of advanced stomach cancer
Judith Meza-Junco, Heather-Jane Au, Michael B Sawyer
Cancer Management and Research 2011, 3:57-64
Published Date: 3 March 2011
Cardiovascular risk during hormonal treatment in patients with prostate cancer
Hein Van Poppel, Bertrand Tombal
Cancer Management and Research 2011, 3:49-55
Published Date: 2 March 2011
Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes
Katia Maalouf, Elias Baydoun, Sandra Rizk
Cancer Management and Research 2011, 3:39-47
Published Date: 14 February 2011
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
Gina M Mantia-Smaldone, Robert P Edwards, Anda M Vlad
Cancer Management and Research 2011, 3:25-38
Published Date: 30 December 2010
Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management
Emanuele Neri, Lorenzo Faggioni, Lorenzo Cini, et al
Cancer Management and Research 2011, 3:17-24
Published Date: 30 December 2010
From antiangiogenesis to hypoxia: current research and future directions
Christopher Rice, L Eric Huang
Cancer Management and Research 2011, 3:9-16
Published Date: 20 December 2010
Reduced cancer risk in vegetarians: an analysis of recent reports
Amy Joy Lanou, Barbara Svenson
Cancer Management and Research 2011, 3:1-8
Published Date: 20 December 2010